Related references
Note: Only part of the references are listed.Temporal and spatial effects and survival outcomes associated with concordance between tissue and blood KRAS alterations in the pan-cancer setting
Kristina Mardinian et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer
Emilie Moati et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal Cancer
Rohan Gupta et al.
ONCOLOGIST (2020)
Therapeutic Monitoring of Circulating DNA Mutations in Metastatic Cancer with Personalized Digital PCR
Christina M. Wood-Bouwens et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancer
Elena Elez et al.
MOLECULAR ONCOLOGY (2019)
BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study
Leo Mas et al.
CANCERS (2019)
Non-invasive genotyping of metastatic colorectal cancer using circulating cell free DNA
Xuemei Shi et al.
CANCER GENETICS (2019)
Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer
Hiroki Osumi et al.
SCIENTIFIC REPORTS (2019)
Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
Lucie Benesova et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer
John H. Strickler et al.
CANCER DISCOVERY (2018)
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
J. B. Bachet et al.
ANNALS OF ONCOLOGY (2018)
Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer
Giovanni Germano et al.
CLINICAL COLORECTAL CANCER (2018)
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)
Jessica Gasparello et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
Matteo Allegretti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
Christina Demuth et al.
TRANSLATIONAL ONCOLOGY (2018)
Precision diagnostics of Ewing's sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts
Matteo Allegretti et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Collin M. Blakely et al.
NATURE GENETICS (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics
Dearbhaile C. Collins et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
Eveline E. Vietsch et al.
CANCER GENETICS (2017)
The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
Lele Song et al.
SCIENTIFIC REPORTS (2017)
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
J. Vidal et al.
ANNALS OF ONCOLOGY (2017)
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
Thomas Reinert et al.
GUT (2016)
Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer
Laura Ciarloni et al.
CLINICAL CANCER RESEARCH (2016)
Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
Jerome Alexandre Denis et al.
MOLECULAR ONCOLOGY (2016)
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma
Anna Maria Rachiglio et al.
ONCOTARGET (2016)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
A. Rose Brannon et al.
GENOME BIOLOGY (2014)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Interpreting diagnostic test accuracy studies
Patrick M. M. Bossuyt
SEMINARS IN HEMATOLOGY (2008)
Share Paper
